0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Localized Autoimmune Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-14U4117
Home | Market Reports | Health| Health Conditions
Global Localized Autoimmune Disease Diagnostics Market Insights and Forecast to 2028
BUY CHAPTERS

Localized Autoimmune Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14U4117
Report
September 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Localized Autoimmune Disease Diagnostics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Localized Autoimmune Disease Diagnostics - Market

Localized Autoimmune Disease Diagnostics - Market

The global market for Localized Autoimmune Disease Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Localized Autoimmune Disease Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Localized Autoimmune Disease Diagnostics by region & country, by Type, and by Application.
The Localized Autoimmune Disease Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Localized Autoimmune Disease Diagnostics.
Market Segmentation

Scope of Localized Autoimmune Disease Diagnostics - Market Report

Report Metric Details
Report Name Localized Autoimmune Disease Diagnostics - Market
CAGR 5%
Segment by Type:
Segment by Application
  • Hospital
  • Clinic
  • Research Institute
  • Laboratories
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Hoffmann-La Roche Ltd, Siemens Healthineers, Abbott Laboratories, Beckman Coulter, Inc., SQI Diagnostics, Quest Diagnostics, EUROIMMUN AG, AESKU.Diagnostics GmbH & Co. KG, INOVA Diagnostics, Inc., Crescendo Bioscience, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., Hemagen Diagnostics, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Localized Autoimmune Disease Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Localized Autoimmune Disease Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Localized Autoimmune Disease Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Localized Autoimmune Disease Diagnostics - Market report?

Ans: The main players in the Localized Autoimmune Disease Diagnostics - Market are Hoffmann-La Roche Ltd, Siemens Healthineers, Abbott Laboratories, Beckman Coulter, Inc., SQI Diagnostics, Quest Diagnostics, EUROIMMUN AG, AESKU.Diagnostics GmbH & Co. KG, INOVA Diagnostics, Inc., Crescendo Bioscience, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., Hemagen Diagnostics, Inc.

What are the Application segmentation covered in the Localized Autoimmune Disease Diagnostics - Market report?

Ans: The Applications covered in the Localized Autoimmune Disease Diagnostics - Market report are Hospital, Clinic, Research Institute, Laboratories

What are the Type segmentation covered in the Localized Autoimmune Disease Diagnostics - Market report?

Ans: The Types covered in the Localized Autoimmune Disease Diagnostics - Market report are Multiple Sclerosis, Type 1 Diabetes, Hashimoto's Thyroiditis, Idiopathic Thrombocytopenic Purpura, Others

Recommended Reports

Diagnostics And Testing

Autoimmune Disease Care

Specialty Diagnostics

1 Market Overview
1.1 Localized Autoimmune Disease Diagnostics Product Introduction
1.2 Global Localized Autoimmune Disease Diagnostics Market Size Forecast
1.3 Localized Autoimmune Disease Diagnostics Market Trends & Drivers
1.3.1 Localized Autoimmune Disease Diagnostics Industry Trends
1.3.2 Localized Autoimmune Disease Diagnostics Market Drivers & Opportunity
1.3.3 Localized Autoimmune Disease Diagnostics Market Challenges
1.3.4 Localized Autoimmune Disease Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Localized Autoimmune Disease Diagnostics Players Revenue Ranking (2023)
2.2 Global Localized Autoimmune Disease Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Localized Autoimmune Disease Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Localized Autoimmune Disease Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Localized Autoimmune Disease Diagnostics
2.6 Localized Autoimmune Disease Diagnostics Market Competitive Analysis
2.6.1 Localized Autoimmune Disease Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Localized Autoimmune Disease Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Localized Autoimmune Disease Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Multiple Sclerosis
3.1.2 Type 1 Diabetes
3.1.3 Hashimoto's Thyroiditis
3.1.4 Idiopathic Thrombocytopenic Purpura
3.1.5 Others
3.2 Global Localized Autoimmune Disease Diagnostics Sales Value by Type
3.2.1 Global Localized Autoimmune Disease Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Localized Autoimmune Disease Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Localized Autoimmune Disease Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Research Institute
4.1.4 Laboratories
4.2 Global Localized Autoimmune Disease Diagnostics Sales Value by Application
4.2.1 Global Localized Autoimmune Disease Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Localized Autoimmune Disease Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Localized Autoimmune Disease Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Localized Autoimmune Disease Diagnostics Sales Value by Region
5.1.1 Global Localized Autoimmune Disease Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Localized Autoimmune Disease Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Localized Autoimmune Disease Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Localized Autoimmune Disease Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
5.2.2 North America Localized Autoimmune Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
5.3.2 Europe Localized Autoimmune Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Localized Autoimmune Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
5.5.2 South America Localized Autoimmune Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Localized Autoimmune Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Localized Autoimmune Disease Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Localized Autoimmune Disease Diagnostics Sales Value
6.3 United States
6.3.1 United States Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
6.3.2 United States Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Localized Autoimmune Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
6.4.2 Europe Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Localized Autoimmune Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
6.5.2 China Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Localized Autoimmune Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
6.6.2 Japan Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Localized Autoimmune Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Localized Autoimmune Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Localized Autoimmune Disease Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Localized Autoimmune Disease Diagnostics Sales Value, 2019-2030
6.9.2 India Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Localized Autoimmune Disease Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Hoffmann-La Roche Ltd
7.1.1 Hoffmann-La Roche Ltd Profile
7.1.2 Hoffmann-La Roche Ltd Main Business
7.1.3 Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.1.4 Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Hoffmann-La Roche Ltd Recent Developments
7.2 Siemens Healthineers
7.2.1 Siemens Healthineers Profile
7.2.2 Siemens Healthineers Main Business
7.2.3 Siemens Healthineers Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.2.4 Siemens Healthineers Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 Siemens Healthineers Recent Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Profile
7.3.2 Abbott Laboratories Main Business
7.3.3 Abbott Laboratories Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.3.4 Abbott Laboratories Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Beckman Coulter, Inc. Recent Developments
7.4 Beckman Coulter, Inc.
7.4.1 Beckman Coulter, Inc. Profile
7.4.2 Beckman Coulter, Inc. Main Business
7.4.3 Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.4.4 Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Beckman Coulter, Inc. Recent Developments
7.5 SQI Diagnostics
7.5.1 SQI Diagnostics Profile
7.5.2 SQI Diagnostics Main Business
7.5.3 SQI Diagnostics Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.5.4 SQI Diagnostics Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 SQI Diagnostics Recent Developments
7.6 Quest Diagnostics
7.6.1 Quest Diagnostics Profile
7.6.2 Quest Diagnostics Main Business
7.6.3 Quest Diagnostics Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.6.4 Quest Diagnostics Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Quest Diagnostics Recent Developments
7.7 EUROIMMUN AG
7.7.1 EUROIMMUN AG Profile
7.7.2 EUROIMMUN AG Main Business
7.7.3 EUROIMMUN AG Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.7.4 EUROIMMUN AG Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 EUROIMMUN AG Recent Developments
7.8 AESKU.Diagnostics GmbH & Co. KG
7.8.1 AESKU.Diagnostics GmbH & Co. KG Profile
7.8.2 AESKU.Diagnostics GmbH & Co. KG Main Business
7.8.3 AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.8.4 AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 AESKU.Diagnostics GmbH & Co. KG Recent Developments
7.9 INOVA Diagnostics, Inc.
7.9.1 INOVA Diagnostics, Inc. Profile
7.9.2 INOVA Diagnostics, Inc. Main Business
7.9.3 INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.9.4 INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 INOVA Diagnostics, Inc. Recent Developments
7.10 Crescendo Bioscience, Inc.
7.10.1 Crescendo Bioscience, Inc. Profile
7.10.2 Crescendo Bioscience, Inc. Main Business
7.10.3 Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.10.4 Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Crescendo Bioscience, Inc. Recent Developments
7.11 bioMerieux SA
7.11.1 bioMerieux SA Profile
7.11.2 bioMerieux SA Main Business
7.11.3 bioMerieux SA Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.11.4 bioMerieux SA Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 bioMerieux SA Recent Developments
7.12 Bio-Rad Laboratories, Inc.
7.12.1 Bio-Rad Laboratories, Inc. Profile
7.12.2 Bio-Rad Laboratories, Inc. Main Business
7.12.3 Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.12.4 Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Bio-Rad Laboratories, Inc. Recent Developments
7.13 Hemagen Diagnostics, Inc.
7.13.1 Hemagen Diagnostics, Inc. Profile
7.13.2 Hemagen Diagnostics, Inc. Main Business
7.13.3 Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Products, Services and Solutions
7.13.4 Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Revenue (US$ Million) & (2019-2024)
7.13.5 Hemagen Diagnostics, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Localized Autoimmune Disease Diagnostics Industrial Chain
8.2 Localized Autoimmune Disease Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Localized Autoimmune Disease Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Localized Autoimmune Disease Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Localized Autoimmune Disease Diagnostics Market Trends
    Table 2. Localized Autoimmune Disease Diagnostics Market Drivers & Opportunity
    Table 3. Localized Autoimmune Disease Diagnostics Market Challenges
    Table 4. Localized Autoimmune Disease Diagnostics Market Restraints
    Table 5. Global Localized Autoimmune Disease Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Localized Autoimmune Disease Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Localized Autoimmune Disease Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Localized Autoimmune Disease Diagnostics
    Table 10. Global Localized Autoimmune Disease Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Localized Autoimmune Disease Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Localized Autoimmune Disease Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Localized Autoimmune Disease Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Localized Autoimmune Disease Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Localized Autoimmune Disease Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Localized Autoimmune Disease Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Localized Autoimmune Disease Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Localized Autoimmune Disease Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Localized Autoimmune Disease Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Localized Autoimmune Disease Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Localized Autoimmune Disease Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Localized Autoimmune Disease Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Localized Autoimmune Disease Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Localized Autoimmune Disease Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Localized Autoimmune Disease Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Localized Autoimmune Disease Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Localized Autoimmune Disease Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Localized Autoimmune Disease Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Localized Autoimmune Disease Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Hoffmann-La Roche Ltd Basic Information List
    Table 32. Hoffmann-La Roche Ltd Description and Business Overview
    Table 33. Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of Hoffmann-La Roche Ltd (2019-2024)
    Table 35. Hoffmann-La Roche Ltd Recent Developments
    Table 36. Siemens Healthineers Basic Information List
    Table 37. Siemens Healthineers Description and Business Overview
    Table 38. Siemens Healthineers Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of Siemens Healthineers (2019-2024)
    Table 40. Siemens Healthineers Recent Developments
    Table 41. Abbott Laboratories Basic Information List
    Table 42. Abbott Laboratories Description and Business Overview
    Table 43. Abbott Laboratories Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of Abbott Laboratories (2019-2024)
    Table 45. Abbott Laboratories Recent Developments
    Table 46. Beckman Coulter, Inc. Basic Information List
    Table 47. Beckman Coulter, Inc. Description and Business Overview
    Table 48. Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of Beckman Coulter, Inc. (2019-2024)
    Table 50. Beckman Coulter, Inc. Recent Developments
    Table 51. SQI Diagnostics Basic Information List
    Table 52. SQI Diagnostics Description and Business Overview
    Table 53. SQI Diagnostics Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of SQI Diagnostics (2019-2024)
    Table 55. SQI Diagnostics Recent Developments
    Table 56. Quest Diagnostics Basic Information List
    Table 57. Quest Diagnostics Description and Business Overview
    Table 58. Quest Diagnostics Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of Quest Diagnostics (2019-2024)
    Table 60. Quest Diagnostics Recent Developments
    Table 61. EUROIMMUN AG Basic Information List
    Table 62. EUROIMMUN AG Description and Business Overview
    Table 63. EUROIMMUN AG Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of EUROIMMUN AG (2019-2024)
    Table 65. EUROIMMUN AG Recent Developments
    Table 66. AESKU.Diagnostics GmbH & Co. KG Basic Information List
    Table 67. AESKU.Diagnostics GmbH & Co. KG Description and Business Overview
    Table 68. AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of AESKU.Diagnostics GmbH & Co. KG (2019-2024)
    Table 70. AESKU.Diagnostics GmbH & Co. KG Recent Developments
    Table 71. INOVA Diagnostics, Inc. Basic Information List
    Table 72. INOVA Diagnostics, Inc. Description and Business Overview
    Table 73. INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of INOVA Diagnostics, Inc. (2019-2024)
    Table 75. INOVA Diagnostics, Inc. Recent Developments
    Table 76. Crescendo Bioscience, Inc. Basic Information List
    Table 77. Crescendo Bioscience, Inc. Description and Business Overview
    Table 78. Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of Crescendo Bioscience, Inc. (2019-2024)
    Table 80. Crescendo Bioscience, Inc. Recent Developments
    Table 81. bioMerieux SA Basic Information List
    Table 82. bioMerieux SA Description and Business Overview
    Table 83. bioMerieux SA Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of bioMerieux SA (2019-2024)
    Table 85. bioMerieux SA Recent Developments
    Table 86. Bio-Rad Laboratories, Inc. Basic Information List
    Table 87. Bio-Rad Laboratories, Inc. Description and Business Overview
    Table 88. Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of Bio-Rad Laboratories, Inc. (2019-2024)
    Table 90. Bio-Rad Laboratories, Inc. Recent Developments
    Table 91. Hemagen Diagnostics, Inc. Basic Information List
    Table 92. Hemagen Diagnostics, Inc. Description and Business Overview
    Table 93. Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Localized Autoimmune Disease Diagnostics Business of Hemagen Diagnostics, Inc. (2019-2024)
    Table 95. Hemagen Diagnostics, Inc. Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Localized Autoimmune Disease Diagnostics Downstream Customers
    Table 99. Localized Autoimmune Disease Diagnostics Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Localized Autoimmune Disease Diagnostics Product Picture
    Figure 2. Global Localized Autoimmune Disease Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Localized Autoimmune Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Localized Autoimmune Disease Diagnostics Report Years Considered
    Figure 5. Global Localized Autoimmune Disease Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Localized Autoimmune Disease Diagnostics Revenue in 2023
    Figure 7. Localized Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Multiple Sclerosis Picture
    Figure 9. Type 1 Diabetes Picture
    Figure 10. Hashimoto's Thyroiditis Picture
    Figure 11. Idiopathic Thrombocytopenic Purpura Picture
    Figure 12. Others Picture
    Figure 13. Global Localized Autoimmune Disease Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Localized Autoimmune Disease Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Hospital
    Figure 16. Product Picture of Clinic
    Figure 17. Product Picture of Research Institute
    Figure 18. Product Picture of Laboratories
    Figure 19. Global Localized Autoimmune Disease Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Localized Autoimmune Disease Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Localized Autoimmune Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Localized Autoimmune Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Localized Autoimmune Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Localized Autoimmune Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Localized Autoimmune Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Localized Autoimmune Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Localized Autoimmune Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Localized Autoimmune Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Localized Autoimmune Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Localized Autoimmune Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Localized Autoimmune Disease Diagnostics Sales Value (%), (2019-2030)
    Figure 32. United States Localized Autoimmune Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Localized Autoimmune Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Localized Autoimmune Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Localized Autoimmune Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Localized Autoimmune Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Localized Autoimmune Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Localized Autoimmune Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Localized Autoimmune Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Localized Autoimmune Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Localized Autoimmune Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Localized Autoimmune Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Localized Autoimmune Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Localized Autoimmune Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Localized Autoimmune Disease Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Localized Autoimmune Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 53. Localized Autoimmune Disease Diagnostics Industrial Chain
    Figure 54. Localized Autoimmune Disease Diagnostics Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS